Praveg Ltd

Mon 7/09/2026,15:58:6 | NSE : PRAVEG

₹264.55-1.60 (-0.60%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 268.80

Previous Close

₹ 266.15

Volume

17250

Mkt Cap ( ₹ Cr)

₹ 691.55

High

₹ 268.80

Low

₹ 262.55

52 Week High

₹ 325.00

52 Week Low

₹ 210.40

Book Value Per Share

₹ 166.76

Dividend Yield

0.18

Face Value

₹ 10.00

What's Your Call?

Collective community sentiment on Praveg Ltd

Your Vote -

Buy

48.48%

Hold

33.33%

Sell

18.18%

48.48%

33 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

NaN%

Sell Order Quantity

NaN%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Praveg Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Praveg - Business Responsibility and Sustainability Reporting (BRSR)

    3 Sep 2026, 8:29PM Business Responsibility and Sustainability Reporting (BRSR) for the financial year 2025-26

  • Praveg - Reg. 34 (1) Annual Report.

    3 Sep 2026, 8:27PM Pursuant to Regulation 34(1) of Securities and Exchange Board of India (Listing Obligations and Disclosure\r\nRequirements) Regulations, 2015, we are

  • Praveg - Notice Of 31St Annual General Meeting Along With Integrated Annual Report Of The Company For The Financial Year 2025

    3 Sep 2026, 8:20PM Notice of 31st Annual general Meeting along with Integrated Annual Report of the Company for the financial year 2025-26.

  • Praveg - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    22 Aug 2026, 7:45PM Pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the details of voti

  • Praveg - Shareholder Meeting / Postal Ballot-Outcome of EGM

    21 Aug 2026, 3:22PM Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (\SEBI Listing Regulations\) read with SEBI

  • Praveg - Announcement under Regulation 30 (LODR)-Investor Presentation

    14 Aug 2026, 6:41PM Investor presentation on unaudited financial results of the Company for the quarter ended June 30, 2026.

  • Praveg - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    13 Aug 2026, 6:55PM This is in continuation to our earlier letter today dated August 13, 2026 wherein the Consolidated and Standalone Unaudited Financial Results of the C

  • Praveg - Unaudited Financial Results (Consolidated And Standalone) Of The Company For The Quarter Ended June 30, 2026

    13 Aug 2026, 4:36PM The Board of Directors of the Company, at its meeting held on August 13, 2026, considered and approved the Unaudited Financial Results (Consolidated a

  • Praveg - Board Meeting Outcome for Outcome Of The Board Meeting Held On August 13, 2026

    13 Aug 2026, 4:30PM In continuation of our intimation dated August 5, 2026 and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Reg

  • Praveg - Board Meeting Intimation for Consideration And Approval Of The Standalone And Consolidated Unaudited Financial Resul

    5 Aug 2026, 6:30PM Praveg Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve t

  • Praveg - Shareholder Meeting - EGM On August 21, 2026

    30 Jul 2026, 7:31PM This is to inform that the Extra-Ordinary General Meeting ('EGM') of the Company will be held on Friday, August 21, 2026 at 11:30 a.m. through Video C

  • Praveg - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    22 Jul 2026, 5:39PM Please find enclosed Press Release on Issue of 8,33,700 Equity Shares and 11,00,000 Convertible Warrants on Preferential Basis.

  • Praveg - Announcement under Regulation 30 (LODR)-Preferential Issue

    22 Jul 2026, 5:07PM The Board approved issuance of 8,33,700 equity shares and 11,00,000 convertible warrants, on preferential basis.

  • Praveg - Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. July 22, 2026

    22 Jul 2026, 5:01PM the Board of Directors ('Board') of the Company, at its meeting held today i.e. July 22, 2026 have approved, inter alia, the following: i) The issuanc

  • Praveg has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    20 Jul 2026, 12:30PM As of June 2026, 46.19% is owned by Indian Promoters and 53.82% by Public. <p align=justify> Top five Promoters holding highest number of shares of Pr

  • Praveg - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    18 Jul 2026, 7:19PM Outcome of remote e-voting and e-voting at the NCLT Conveyed Meeting of the Equity Shareholders of Praveg Limited including scrutinizer's report

  • Praveg - Shareholder Meeting / Postal Ballot-Outcome of Court Convened Meeting

    18 Jul 2026, 7:05PM Proceedings of the Meeting of the Equity Shareholders of Praveg Limited ('the Company') convened as per the directions of the Hon'ble National Company

  • Praveg - Board Meeting Intimation for Consideration And Approval Of The Issuance Of Equity Shares Or Warrants Or Conversion O

    16 Jul 2026, 8:06PM Praveg Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/07/2026 ,inter alia, to consider and approve a

  • Praveg - Board Meeting Outcome for Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirement

    13 Jul 2026, 6:20PM Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with

  • Praveg - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    8 Jul 2026, 6:35PM Pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, please find enclosed a c

  • Praveg - NCLT Convened Meeting Scheduled On July 18, 2026

    18 Jun 2026, 12:00AM NCLT convened Meeting Scheduled on July 18, 2026

  • Praveg announces Hotel Management agreement with the Indian Hotels

    3 Mar 2025 , 3:21PM Praveg inks Hotel Management agreement with IHCL for Lakshadweep resort
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Praveg Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 476.7261 457.8943 287.7886 112.8745 30.9841
Liabilities 476.7261 457.8943 287.7886 112.8745 30.9841
Equity 26.1407 26.1407 24.5326 20.9221 18.4841
Gross Profit 30.685 38.7332 29.0812 44.8642 19.7012
Net Profit -12.0895 12.8629 12.8935 28.3802 12.2278
Cash From Operating Activities 38.5938 19.8661 16.9163 25.2123 6.5971
NPM(%) -6.58 9.69 14.1 33.63 27.17
Revenue 183.6265 132.6273 91.4175 84.3792 44.9886
Expenses 152.9415 93.8941 62.3363 39.515 25.2874
ROE(%) -2.77 2.95 2.95 6.51 2.8

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
0.5 5 0.19 272.2

Peers

Other companies within the same industry or sector that are comparable to Praveg Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 863.00 0.32 21.83 151.98 -26.19 0.58
Lotus Eye Hospital and Institute Ltd 109.06 -0.34 1558.00 553.81 0.39 0.00
Vaishali Pharma Ltd 8.37 0.60 26.16 3474.21 15.42 0.00
Astec Lifesciences Ltd 552.35 -0.38 0.00 593.37 -363.14 0.00

Company Info

Sword and Shield Pharma Ltd was incorporated as a Public Limited company on 28th February, 1995 with the Registrar of Companies, Gujarat State, Ahmedabad and obtained Certificate of Commencement of Business on 7th March, 1995. The Copmany was promoted by experienced entrepreneurs with a proven track record of marketing of different pharmaceuucal formulations. The Company has proposed the project at the cost of Rs.515.00 Lacs for manufacturing and marketing of different pharmaceutical formulations. The Company has started the implementation of the project by acquisition of land, admeasuring 3650 sq. yards, at village Indrad, Dist. Kadi, Gujarat. The N.A. Approval for the land is already obtained by the Company. The necessary application to Gujarat Electricity Board and Gujarat Pollution Board are already being made. 2020 -Company name has changed to Praveg Communications (India) Ltd. from Sword & Shield Pharma Ltd.. 2021 -Company Has Been Recognized As The Runner Up In The Category Of Best Eco Resort In Gujarat At Gujarat Travel & Tourism Excellence Award 2021. 2023 -Company name changed to Praveg Ltd. from Praveg Communications (India) Ltd.

Sword and Shield Pharma Ltd was incorporated as a Public Limited company on 28th February, 1995 with the Registrar of Companies, Gujarat State, Ahmedabad and obtained Certificate of Commencement of Business on 7th March, 1995. The Copmany was promoted by experienced entrepreneurs with a proven track record of marketing of different pharmaceuucal formulations. The Company has proposed the project at the cost of Rs.515.00 Lacs for manufacturing and marketing of different pharmaceutical formulations. The Company has started the implementation of the project by acquisition of land, admeasuring 3650 sq. yards, at village Indrad, Dist. Kadi, Gujarat. The N.A. Approval for the land is already obtained by the Company. The necessary application to Gujarat Electricity Board and Gujarat Pollution Board are already being made. 2020 -Company name has changed to Praveg Communications (India) Ltd. from Sword & Shield Pharma Ltd.. 2021 -Company Has Been Recognized As The Runner Up In The Category Of Best Eco Resort In Gujarat At Gujarat Travel & Tourism Excellence Award 2021. 2023 -Company name changed to Praveg Ltd. from Praveg Communications (India) Ltd.

Parent Organisation

Praveg Ltd.

Founded

28/02/1995

Managing Director

NSE Symbol

PRAVEGEQ

FAQ